Develops capsule endoscopy technology to detect colorectal polyps and cancer without requiring bowel preparation.
Check-Cap Ltd., a clinical-stage medical diagnostics company based in Isfiya, Israel, specializes in developing advanced capsule-based screening technology. This innovative approach utilizes ultra-low-dose X-rays to scan the inner lining of the colon, aiming to detect precancerous polyps and other structural abnormalities. The cornerstone of Check-Cap's offerings is the C-Scan system, which includes the C-Scan Cap a capsule equipped for X-ray scanning to identify suspected polyps. Complementing this is the C-Scan Track, a disposable system affixed to the patient's back using biocompatible adhesive skin patches. The C-Scan View software, a client/server-based application, facilitates procedure data download from the C-Scan Track, data analysis, and report generation.
Founded in 2004, Check-Cap Ltd. has established itself as a pioneer in non-invasive colon cancer screening technologies. The company's mission is to provide effective tools that enhance early detection and treatment of gastrointestinal conditions, thereby improving patient outcomes and reducing healthcare costs. By leveraging its expertise in medical imaging and diagnostic solutions, Check-Cap continues to innovate in the field of gastrointestinal health, aiming to address significant unmet medical needs globally.
Headquartered in Isfiya, Israel, Check-Cap Ltd. remains committed to advancing its C-Scan technology and expanding its capabilities. With a focus on rigorous clinical research and regulatory approvals, the company aims to make its innovative screening solution widely accessible, offering a non-invasive alternative for early detection and prevention of colorectal cancer and other gastrointestinal diseases.